Animal models of HIV-associated nephropathy

Current Opinion in Nephrology and Hypertension

Volumn 15, Issue 3, 2006, Pages 233-237

  Lu, Ting Chi ^a   He, John Cijiang ^a   Klotman, Paul ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Box 1118 ^*  (United States)

Author keywords

Animal model; Collapsing focal segmental glomerulosclerosis; HIV associated nephropathy

Indexed keywords

NEF PROTEIN; VPR PROTEIN;

DISEASE MODEL; EPITHELIUM CELL; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 ASSOCIATED NEPHROPATHY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERSTITIAL NEPHRITIS; KIDNEY CELL; KIDNEY DISEASE; KIDNEY EPITHELIUM; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RHESUS MONKEY; STRUCTURAL GENE; TRANSGENIC ANIMAL; TRANSGENIC MOUSE; TRANSGENIC RAT; TUBULAR DYSFUNCTION; UREMIA; VIRUS DETECTION; VIRUS GENE;

AIDS-ASSOCIATED NEPHROPATHY; ANIMALS; GENES, GAG; GENES, POL; HIV-1; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; PRIMATES; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33646786140     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000222688.69217.8e     Document Type: Review

References (47)

1. Rao T, Filippone E, Nicastri A, et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984; 310:669-673.
2. US Renal Data System (USRDS) 2001 annual data report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases' 2001.
3. Winston J, Klotman M, Klotman P. HIV-1 associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999; 55:1036-1040.
4. Carbone L, D'Agati V, Cheng J, Appel G. Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 1989; 87:389-395.
5. Laradi A, Mallet A, Beaufils H, et al. HIV-associated nephropathy: outcome and prognosis factors. J Am Soc Nephrol 1998; 9:2327-2335.
6. Wali R, Drachenberg C, Papadimitriou J, et al. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998; 352:783-784.
7. Levin M, Palella F, Shah S, et al. HIV-associated nephropathy occurring before HIV antibody seroconversion. Am J Kidney Dis 2001; 37:E39.
8. Winston J, Bruggeman L, Ross M, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344:1979-1984.
9. Lucas G, Eustace J, Sozio S, et al. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004; 18:541-546.
10. Abbott K, Hypolite I, Welch P, Agodoa L. Human immunodeficiency virus/ acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol 2001; 14:377-383.
11. Ross M, Klotman P. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol 2002; 13:2997-3004.
12. D'Agati V, Suh J, Carbone L, et al. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int 1989; 35:1358-1370.
13. D'Agati V, Appel G. HIV infection and the kidney. J Am Soc Nephrol 1997; 8:138-152.
14. Chander P, Agarwal A, Soni A, et al. Renal cytomembranous inclusions in idiopathic renal disease as predictive markers for the acquired immunodeficiency syndrome. Hum Pathol 1988; 19:1060-1064.
15. Dickie P, Felser J, Eckhaus M, et al. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 1991; 185:109-119.
16. Kopp J, Klotman M, Adler S, et al. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type I genes. Proc Natl Acad Sci U S A 1992; 89:1577-1581.
17. Bruggeman L, Dikman S, Meng C, et al. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997; 100:84-92.
18. Gharavi A, Ahmad T, Wong R, et al. Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A 2004; 101:2488-2493.
19. Nelson P, D'Agati V, Gries J, et al. Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol. J Antimicrob Chemother 2003; 51:921-929.
20. Gherardi D, D'Agati V, Chu T, et al. Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol 2004; 15:1212-1222.
21. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999; 10:51-61.
22. Barisoni L, Bruggeman L, Mundel P, et al. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 2000; 58:173-181.
23. Barisoni L, Mokrzycki M, Sablay L, et al. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 2000; 58:137-143.
24. Shankland S, Eitner F, Hudkins K, et al. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int 2000; 58:674-683.
25. Husain M, Gusella G, Klotman M, et al. HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol 2002; 13:1806-1815.
26. He J, Husain M, Sunamoto M, et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 2004; 114:643-651.
27. Schwartz E, Cara A, Snoeck H, et al. Human Immunodeficiency Virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 2001; 12:1677-1684.
28. Zhong J, Zuo Y, Fogo A, et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 2005; 68:1048-1060. A new murine model with podocyte-specific expression of HIV-1 genes is developed. Detailed pathologic study of these mice is provided and the study highlights the central role of podocyte dysfunction in HIVAN pathogenesis.
29. Hanna Z, Kay D, Cool M, et al. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J Virol 1998; 72:121-132.
30. Hanna Z, Kay D, Rebai N, et al. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 1998; 95:163-175.
31. Hanna Z, Weng X, Kay D, et al. The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J Virol 2001; 75:9378-9392.
32. Husain M, D'Agati V, He J, et al. HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 2005; 19:1975-1980. A new murine model with podocyte-specific expression of the viral protein Nef is described. Early evidence of podocyte loss of differentiation markers and expression of proliferation markers is described. The study suggests a central role for Nef in instigating podocyte dysfunction.
33. Kajiyama W, Kopp J, Marinos N, et al. Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef. Kidney Int 2000; 58:1148-1159.
34. Andersen JL, Planelles V. The role of Vpr in HIV-1 pathogenesis. Curr HIV Res 2005; 3:43-51.
35. Dickie P, Roberts A, Uwiera R, et al. Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy. Virology 2004; 322:69-81.
36. Eremina V, Sood M, Haigh J, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111:707-716.
37. Morini M, Benelli R, Giunciuglio D, et al. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology. Biochem Biophys Res Commun 2000; 273:267-271.
38. Barisoni L, Madaio M, Eraso M, et al. The kd/kd mouse is a model of collapsing glomerulopathy. J Am Soc Nephrol 2005; 16:2847-2851. A detailed morphologic comparison of the glomerular changes in the kd/kd mouse model with the HIV-1 transgenic mouse model.
39. Kanki P, McLane M, King N, et al. Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science 1985; 228:1199-1201.
40. Hirsch V, Olmsted R, Murphey-Corb M, et al. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 1989; 339:389-392.
41. Benveniste R, Morton W, Clark E, et al. Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J Virol 1988; 62:2091-2101.
42. Gattone V, Tian C, Zhuge W, et al. SIV-associated nephropathy in rhesus macaques infected with lymphocyte-tropic SIVmac239. AIDS Res Hum Retroviruses 1998; 14:1168-1180.
43. macR71 /17E) exhibit extensive focal segmental and global glomerulosclerosis. J Virol 1998; 72:8820-8832.
44. Liu Z, Muhkerjee S, Sahni M, et al. Derivation and biological characteristics of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease and renal disease in rhesus macaques. Virology 1999; 260:295-307.
45. Stephens E, Tian C, Dalton S, Gattone V. Simian-human immunodeficiency virus-associated nephropathy in macaques. AIDS Res Hum Retroviruses 2000; 16:1295-1306.
46. Reid W, Sadowska M, Denaro F, et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 2001; 98:9271-9276.
47. Ray P, Liu X, Robinson L, et al. A novel HIV-1 transgenic rat model of childhood HIV-1 associated nephropathy. Kidney Int 2003; 63:2242-2253.